Translational Scientist

Location: Stratford, London

Salary: £43k - £53k + benefits

Contract: Permanent, full time

Please note that we will be shortlisting for interview on a rolling basis so early application is strongly encouraged to avoid any disappointment.

Are you a Translational scientist with broad experience across preclinical and early clinical development? Could you help us plan and implement pharmacology and toxicology packages to support submissions for vaccines, cell therapies or biologicals?

Why we need you

Johnson Matthey (JM) has an exciting opportunity for a Laboratory, Facilities & Quality Assistant to join our Health Sector. Operating from a state-of-the-art facility in Cambridge, we are world leaders in solid state science and crystallisation development. Our services currently include solid-form and physicochemical profiling, salt/polymorph, co-crystal screening and selection, and scale up of forms.

Key responsibilities:

The Vertebrate Genomics team are looking for a talented and motivated Project Leader to manage the NHGRI-EBI GWAS Catalog. The GWAS Catalog ( is a high quality repository of all published genome wide association studies and is the leading international GWAS repository. It is considered the “go-to” resource for genetic evidence of associations between human genotypes and diseases or phenotypes.

Bruntwood SciTech owns and manages the largest portfolio of science and technology assets in the UK including prestigious locations like Manchester Science Park in Manchester, Alderley Park in Cheshire and Platform in Leeds.

With an expanding small molecule drug discovery portfolio, Artios Pharma is recruiting an experienced Director of Translation Science. This is an excellent opportunity to join a world class research team in a dynamic, fast paced Biotech company based south of Cambridge, UK. Artios is focused on identifying and developing cancer treatments by exploiting novel targets within the DNA damage response (DDR), a scientific area of high expectation following the success of PARP inhibitors in the clinic. The company is actively working on an exciting portfolio of unique DNA repair projects.

Start Date: Immediate preferred

Salary: Competitive compensation package including share options, subject to experience

Closing Date: 6th January 2020

About Healx

We are looking for an experienced Bioinformatician to join us in the exciting role of developing a phylogenetic annotation procedure in one of the world’s leading scientific resources, the Universal Protein resource (UniProt) at the EMBL-European Bioinformatics Institute (EBI) located on the Wellcome Genome Campus near Cambridge in the UK.

Mogrify is a cell therapy development company. We have developed a systematic big data-science approach powered by next-generation sequencing and gene-regulatory data to identify the optimal combination of transcription factors (in vitro) or small molecules (in vivo). This allows the conversion of any mature cell type into any other mature cell type without traversing a pluripotent stem cell- or progenitor cell-state. We are applying this approach to address the issues of efficacy, safety and scalability currently associated with cell therapy development.

Cerevance is a pharmaceutical company harnessing a novel technology platform to deliver life-changing therapeutics for patients with central nervous system diseases. Cerevance is generating a large and diverse human CNS expression and epigenetics data set from which new targets are being identified for innovative drug discovery programmes. We are seeking to recruit a Bioinformatician for a 1 year fixed term contract to provide maternity cover, based in our Cambridge, UK facility. This position has the potential to convert to a full time post, depending on future developments.

Marketing & Customer Support Administrator - Cambridge UK £ COMPETITIVE

PredictImmune Ltd was created in early 2017 as a spin-out from the Department of Medicine, University of Cambridge, UK. It is a new generation molecular diagnostics company offering a unique approach to the prognosis of immune-mediated diseases such as Inflammatory Bowel Disease (IBD), Lupus, Multiple Sclerosis etc.